| Hexanoicacid, 3-(2-amino-2-oxoethyl)-5-methyl-, (3S)- |
普瑞巴林杂质10 |
181289-34-9 |
| 3-(2-Hydroxyethyl)-9-hydroxy-2-Methyl-4H-pyrido[1,2-a]pyriMidin-4-one |
3-(2-羟基乙基)-9-羟基-2-甲基-4H-吡啶并[1,2-A]嘧啶-4-酮 |
181525-38-2 |
| Losartan Trityl Ether |
氯沙坦三苯甲基醚 |
1006062-28-7 |
| O-Acetyl Losartan |
氯沙坦杂质J |
1006062-27-6 |
| (1R,2R)-2-(3,4-difluorophenyl)cyclopropane carboxaMide |
替卡格雷中间体 |
1006376-62-0 |
| 4-methoxy-3-(3-morpholinopropoxy)-2-nitrobenzonitrile |
吉非替尼杂质17 |
1006378-06-8 |
| LY 88074 |
雷洛昔芬杂质D |
177744-96-6 |
| 3,3'-diMethyl-1,1'-diphenyl-1H,1'H-4,4'-bipyrazole-5,5'-diol |
依达拉奉二聚体 |
177415-76-8 |
| Levofloxacin Related Compound C (25 mg) ((S)-ethyl 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylate) |
左氧氟沙星相关物质C |
177472-30-9 |
| 12-ethyl-8-methyl-9-oxo-7-propionyl-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate |
伊立替康杂质4 |
176515-52-9 |
| 4-Amino-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-iodo-2-methoxybenzamide |
4-氨基-N-[(1-乙基-2-吡咯烷基)甲基]-5-碘-2-甲氧基苯甲酰胺 |
176849-91-5 |
| 9-Piperazino Ofloxacin |
氧氟沙星EP杂质D |
197291-75-1 |
| Temozolomide Impurity |
替莫唑胺 3 |
196806-10-7 |
| Raloxifene N-Oxide |
雷洛昔芬杂质C |
195454-31-0 |
| OLANZAPINE N-OXIDE |
奥氮平N-氧化物 |
174794-02-6 |
| Tolterodine Impurity 5 |
托特罗定杂质5 |
173948-30-6 |
| (1S,2S)-1,2-Bis(MethanesulfonyloxyMethyl)cyclohexane |
S,S-环己烷二甲醇磺酸酯 |
173658-50-9 |
| Itraconazole Impurity |
Itraconazole Impurity |
172587-60-9 |
| 6-(1-Bromoethyl)-4-chloro-5-fluoropyrimidine |
4-(1-溴代乙基)-5-氟-6-氯嘧啶 |
188416-28-6 |
| 4-Hydroxy Valsartan, Mixture of Diastereomers |
4-羟基缬沙坦 |
188259-69-0 |
QQ
微信
